Gritstone bio, Inc. Common Stock
GRTS
GRTS was delisted on the 21st of October, 2024.
81 hedge funds and large institutions have $194M invested in Gritstone bio, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 36 increasing their positions, 13 reducing their positions, and 6 closing their positions.
250% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 6
177% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 13
23% more funds holding
Funds holding: 66 → 81 (+15)
10% more capital invested
Capital invested by funds: $176M → $194M (+$18M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$2.18M |
| 2 |
BlackRock
New York
|
+$1.85M |
| 3 |
ACM
Asymmetry Capital Management
San Francisco,
California
|
+$1.5M |
| 4 |
Millennium Management
New York
|
+$1.23M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$1.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$9.45M |
| 2 |
PS
Peter Svennilson
|
-$9.44M |
| 3 |
Victory Capital Management
San Antonio,
Texas
|
-$3.14M |
| 4 |
CC
Casdin Capital
New York
|
-$2.83M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$240K |
GRTS Hedge Fund Activity: Q2 2020 in Review
81 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q2 2020, worth a combined $194M — up 10% from $176M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new GRTS positions and 6 closed out — a net gain of 15 holders — while 36 added to existing stakes and 13 trimmed.
The largest buyer was Ensign Peak Advisors, adding an estimated $2.18M. The largest seller was Fidelity Investments, cutting an estimated $9.45M.
- 81 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q2 2020, up from 66 in Q1 2020.
- Funds reported $194M of Gritstone bio, Inc. Common Stock stock for Q2 2020, up 10% quarter-over-quarter.
- 21 funds opened new Gritstone bio, Inc. Common Stock positions in Q2 2020 and 6 closed out, a net change of +15 holders.
- The largest Gritstone bio, Inc. Common Stock buyer in Q2 2020 was Ensign Peak Advisors, an estimated $2.18M added.
- The largest Gritstone bio, Inc. Common Stock seller in Q2 2020 was Fidelity Investments, an estimated $9.45M sold.
Based on aggregated 13F filings for Q2 2020.